Stocks
Health Care
skye
Skye Bioscience
NASDAQ: SKYE
+0.02 (+2.60%)
0.755
USD
At close at Mar 04, 21:41 UTC
Income Statement
Revenue
-
Gross Profit
-
Operating Income
-30.19M
Pretax Income
-51.22M
Net Income
-26.57M
EBITDA
-25.51M
EBIT
-25.81M
Earnings Per Share
-0.73
Balance Sheet
Cash & Cash Equivalents
80.13M
Total Debt
2.64M
Net Cash
7.06M
Net Cash Per Share
0.23
Equity (Book Value)
73.91M
Book Value Per Share
2.53
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.